In a recent clinical trial, tocilizumab helped sustain glucocorticoid-free remission in patients with giant cell arteritis. Patients also received a prednisone taper, and 50% of tocilizumab-treated patients achieved prednisone-free remission and were less likely to experience disease flare compared with placebo…
![](https://www.the-rheumatologist.org/wp-content/uploads/2016/04/Heart_BrandX_GettyImages_500x270-150x150.jpg)